Middletown, DE -- (SBWIRE) -- 08/19/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Cree, Inc. (NASDAQ:CREE), First Solar, Inc. (NASDAQ:FSLR), Express Scripts Holding Company (NASDAQ:ESRX), Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)
Cree, Inc. (NASDAQ:CREE) reported an upsurge of 2.13%, after opening at the price of $56.20. Its closing price for the day was $57.12. Cree's current market capitalization stands at $6.73 billion, along with 117.87 million shares. Cree, Inc. develops and manufactures lighting-class light emitting diode (LED) products, lighting products, and semiconductor products for power and radio-frequency (RF) applications. Its LED products include blue and green LED chips that are used in various applications, including video screens, gaming displays, function indicator lights, and automotive backlighting.
Why Should Investors Buy CREE After The Recent Gain? Just Go Here and Find Out
First Solar, Inc. (NASDAQ:FSLR), reported to close at $38.16. The stock’s opening price was $37.70. The 52-week price range of the stock remained $18.30 - $59.00, while during last trade its minimum price was $37.63 and it gained its highest price of $38.57. First Solar, Inc. provides solar energy solutions. It operates in two segments, Components and Systems. The Components segment engages in the design, manufacture, and sale of solar modules that convert sunlight into electricity. It primarily serves project developers, system integrators, and operators of renewable energy projects.
Will FSLR Continue To Move Higher? Find Out Here
Express Scripts Holding Company (NASDAQ:ESRX) ended its day with the gain of 1.00% and closed at the price of $64.61, after opening at $63.92. During the previous session, the company’s minimum price was $63.70, while it touched its highest price for the day at $64.81. Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. The companys PBM services comprise retail network pharmacy management; home delivery pharmacy; benefit design consultation; drug utilization review.
For How Long ESRX’s Gloss will Attract Investors? Find out via this report
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) reported the increase of 0.41%, to close at $115.81. During last trade, the company’s minimum price was $114.06, while it touched its highest price of $118.40. Its market capitalization was $8.49 billion. Its beta value stands at 1.33 times and earnings per share was $-1.59. Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms that cause cancer in the United States and internationally.
For How Long ONXX will Fight for Profitability? Read This Trend Analysis report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)